Melissa Edwards
Psychiatric/Mental Health · Irvine, CANPI 1598252173
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,461 and has fallen 91.9% since, to $118 in 2024.
Across 129 payments — averaging $22.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$499
- Sunovion Pharmaceuticals Inc.$305
- Johnson & Johnson$282
- Alkermes, Inc.$251
- Acadia Pharmaceuticals Inc$242
- Vanda Pharmaceuticals Inc.$229
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,87198%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $499 |
| Sunovion Pharmaceuticals Inc. | 12 | $305 |
| Johnson & Johnson | 10 | $282 |
| Alkermes, Inc. | 12 | $251 |
| Acadia Pharmaceuticals Inc | 2 | $242 |
| Vanda Pharmaceuticals Inc. | 9 | $229 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $174 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Neurocrine Biosciences, Inc. | 4 | $81 |
| Adlon Therapeutics L.p. | 3 | $70 |
| Ironshore Pharmaceuticals Inc. | 3 | $70 |
| Viiv Healthcare Company | 3 | $68 |
| Eisai Inc. | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
| Alfasigma USA, Inc. | 2 | $45 |
| Bausch Health US, LLC | 2 | $34 |
| Lundbeck LLC | 1 | $28 |
| Corium, LLC | 2 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Indivior Inc. | 1 | $24 |
| Biogen | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$242
How this compares
$2,918 in reported general payments places this provider in the 85th percentile of 2,433 psychiatric/mental health providers in California.
Other psychiatric/mental health in Irvine
- Phuong TranIrvine$27K
- Dylan GuineyIrvine$25K
- Jada AlstonIrvine$18K
- Maria AcevedoIrvine$15K
- Salina LumIrvine$15K
- Sylvia GuthrieIrvine$14K
- Farhad NikooIrvine$14K
- Kelly EguchiIrvine$12K
- Michelle NguyenIrvine$11K
- Carey MartinMillbrae$745K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.